INSM1 and lung cancer: Abrogation of INSM1 (proposed as target gene for SCLC cancer therapy; Pedersen et al, 2006), that exerts a crosstalk with the sonic hedgehog transcription pathway, and also critical for NE differentiation, by lurbinectedin might also affect the NE lung cancer development.